Morningstar Investor users sign in here.

Company Profile

  • Business description

    AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

  • Contact

    1 North Waukegan Road
    North Chicago IL 60064-6400
    USA

    T: +1 847 932-7900

    E: liz.shea@abbvie.com

    http://www.abbvieinvestor.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2024

    Employees

    50,000

Stocks News & Analysis

stocks

Our only wide moat ASX miner is finally looking to expand

Is the proposed deal a winner for shareholders?
stocks

A 15 step checklist from Buffett's forgotten inspiration

Phil Fisher achieved remarkable stock market returns by holding high quality growth companies for long periods of time. Here's how he found them.
video

Are Guzman's growth targets realistic?

Morningstar Equity Analyst Lochlan Halloway discusses Guzman's upcoming IPO. 

Markets

Index
Last price
Change
% Change
All Ordinaries 7,974.80 27.70 -0.35%
CAC 40 7,503.27 204.75 -2.66%
DAX 40 18,002.02 263.66 -1.44%
Dow JONES (US) 38,589.16 57.94 -0.15%
FTSE 100 8,146.86 16.81 -0.21%
HKSE 17,941.78 170.85 -0.94%
NASDAQ 17,688.88 21.32 0.12%
Nikkei 225 38,814.56 94.09 0.24%
NZX 50 Index 11,864.89 7.75 -0.07%
S&P 500 5,431.60 2.14 -0.04%
S&P/ASX 200 7,724.30 25.40 -0.33%
SSE Composite Index 3,032.63 3.71 0.12%

Market Movers

Name
Last price
Change
% Change
Pilbara Minerals Ltd PLS 3.24 0.08 -2.41%
Peninsula Energy Ltd PEN 0.11 0.01 5.00%
Sayona Mining Ltd SYA 0.04 0.00 -2.70%
Zip Co Ltd ZIP 1.45 0.14 10.27%
Orora Ltd ORA 1.96 0.10 -4.63%
South32 Ltd S32 3.66 0.02 0.55%
Tabcorp Holdings Ltd TAH 0.66 0.06 10.08%
Adbri Ltd ABC 3.19 0.00 0.00%
Resolute Mining Ltd RSG 0.51 0.04 -7.27%
Core Lithium Ltd CXO 0.09 0.00 -2.13%